Results
1 -
10 of
145
(Click
here to explore results)
- Macrocycles in Drug Discovery, CHAPTER 4 Macrocyclic Inhibitors of Zinc-dependent Histone Deacetylases (HDACs). A. Ganesan
, 2015
, Pages 109-140
- Peptide-based Drug Discovery: Challenges and New Therapeutics, CHAPTER 10 Peptide Therapeutics: Oncology. Ruiwu Liu, Xiaocen Li, Tsung-Chieh Shih, Joyce S. Lee, Kit S. Lam
, 2017
, Pages 278-325
- Epigenetics for Drug Discovery, CHAPTER 5 Targeting Histone Acetylation. Daniel Vitt, Roland Baumgartner, Hella Kohlhof
, 2016
, Pages 96-126
- Macrocycles in Drug Discovery, CHAPTER 1 Bioactive Macrocycles from Nature. David J. Newman, Gordon M. Cragg
, 2015
, Pages 1-36
- Epigenetics for Drug Discovery, CHAPTER 9 Who will Benefit from Epigenetic Drugs?. Dominique Verhelle, David J. Shields
, 2016
, Pages 230-248
- DNA-targeting Molecules as Therapeutic Agents, Chapter 5 Computer Simulations of Drug–DNA Interactions: A Personal Journey. Federico Gago
, 2018
, Pages 96-143
- 2-Oxoglutarate-Dependent Oxygenases, CHAPTER 19 Isopenicillin N Synthase. Peter J. Rutledge
, 2015
, Pages 414-424
- Inhibitors of Molecular Chaperones as Therapeutic Agents, CHAPTER 12 The Cancer Super-chaperone Hsp90: Drug Targeting and Post-translational Regulation. Annerleim Walton-Diaz, Sahar Khan, Jane B. Trepel, Mehdi Mollapour, Len Neckers
, 2014
, Pages 318-335
- Epigenetics for Drug Discovery, CHAPTER 12 Safety Considerations for Epigenetic Mechanisms as Drug Targets: Are Existing Toxicology Studies Fit for Purpose?. Paul Butler, Michael Lawton, Robert E. Chapin, Brett D. Hollingshead, Karen Leach, Prashant R. Nambiar, Mathew Pletcher, Amy H. Yang
, 2016
, Pages 288-315
- Synthetic Receptors for Biomolecules: Design Principles and Applications, Chapter 8 Synthetic Receptors for Amino Acids and Peptides. Debrabata Maity, Carsten Schmuck
, 2015
, Pages 326-368